Topic resource collection
Approved comparison material connected to this topic.
479 resourcesRead both sides
MPM presents in three histological subtypes — epithelioid (~60%, better prognosis), sarcomatoid (~20%, worst prognosis, minimal immune infiltration), and biphasic (~20%, mixed). These subtypes have profoundly different TME biolog…
BPC-157 and TB-500 converge on tendon healing via distinct primary mechanisms that are non-overlapping at the molecular initiating event. BPC-157 initiates via VEGFR2 transactivation → FAK → EGR-1-COL1A1 axis, producing angiogeni…
SCLC is defined by near-universal biallelic inactivation of RB1 and TP53, resulting in unconstrained E2F transcriptional activity and loss of p53-dependent apoptosis. SCLC is further subtyped by dominant transcription factor expr…
PRP delivers concentrated growth factors including PDGF-BB (~10–15 ng/mL), TGF-β1 (~150–250 ng/mL), IGF-1 (~50–80 ng/mL), VEGF-A (~20–40 ng/mL), and FGF-2 (~2–5 ng/mL) — all of which activate overlapping tenocyte signalling casca…
Two primary models serve different research questions. LPS endotoxaemia (E. coli LPS 10–15 mg/kg i.p. in C57BL/6J) is preferred for mechanistic studies of the TLR4-NF-κB cytokine storm, gut barrier biology, and microvascular dysf…
BPC-157 Collagen synthesis acceleration via FGF/VEGF pathways 200–500 mcg daily (animal models) 4–6 hours Angiogenesis, nitric oxide production Most studied for tendon repair; partial oral bioavailability in rats; best-documented…
This table compares the primary research-grade peptides used in soft tissue injury recovery, focusing on mechanism, administration, and practical application for ankle sprains. BPC-157 Sustains VEGF and TGF-β signaling through pr…
BPC-157 Angiogenesis via VEGF upregulation; NO pathway modulation Tendons, ligaments, muscle, gastric mucosa Subcutaneous injection near injury site Twice daily (short half-life ~4 hours) Strongest evidence for vascular-dependent…
Kisspeptin-10 Restores GnRH pulsatility, increases LH/FSH Secondary hypogonadism, hypothalamic dysfunction 1–4mcg/kg pulsed every 90 min or 6.4nmol/kg bolus 8–16 weeks for hormonal normalization, 6–12 months for sperm improvement…
BPC-157 Nerve regeneration via VEGFR2 and EGFR upregulation 250–500mcg daily, subcutaneous Multiple animal studies, no human RCTs Strongest evidence for structural nerve repair, zero human safety data for sciatica TB-500 Anti-inf…
This table ranks peptides by mean body weight reduction demonstrated in published randomized controlled trials. Rankings reflect clinical evidence. Not marketing claims or anecdotal reports. Tirzepatide Dual GIP/GLP-1 agonist 20.…
BPC-157 VEGF upregulation, angiogenesis in avascular disc tissue, type I collagen synthesis 250–500 mcg daily (7–10 mcg/kg) subcutaneous 8–12 weeks minimum Rodent models published; human trials limited to case reports Strongest m…
BPC-157 FAK-paxillin activation, VEGF upregulation 200–500 mcg daily High. Stimulates new capillary formation in ischemic zones Moderate. Reduces chronic inflammation markers Best first-line peptide for acute tendon injuries; fas…
BPC-157 Upregulates VEGF and FAK-paxillin pathway; enhances fibroblast migration and collagen synthesis Inflammatory + Proliferative (weeks 0–6) 250–500 mcg/day subcutaneous 4–8 weeks Most evidence-supported for tendon-to-bone in…
Thymalin Restores T-cell differentiation blocked by cortisol mistiming Immune (thymus) 10 mg SC daily × 5–10 days 2–3 hours Addresses immune suppression. Not cognitive symptoms Cerebrolysin Delivers BDNF and NGF to enhance hippoc…
GHK-Cu Copper chelation, MMP modulation, collagen remodeling Topical 2–3mg/mL twice daily 12% increase in follicle density, 18% increase in shaft diameter (24 weeks, Dermatologic Therapy 2023) Best for localized androgenetic alop…
BPC-157 VEGF upregulation, collagen type I synthesis, FAK-paxillin pathway activation Tendons, ligaments, fibrocartilage Rodent tendon studies show 30–40% faster healing at 14 days vs controls 200–500 mcg/day subcutaneous or loca…
Semaglutide (Wegovy) GLP-1 receptor agonist. Appetite suppression + direct adipocyte lipolysis 8.7% reduction at 68 weeks (STEP 1 imaging substudy) 0.25mg → 2.4mg weekly over 16–20 weeks Gold standard for visceral fat loss. FDA-a…
Thymalin Thymic immune restoration; upregulates OGG1, XRCC1 Base excision repair (BER) + immune surveillance 35–40% thymic mass restoration in aged rats (Biogerontology, 2018); increased DNA repair gene expression Subcutaneous in…
Before selecting peptides for OTS recovery, understand how each compound's mechanism aligns with your specific dysregulation pattern. Immune suppression, inflammatory persistence, or autonomic imbalance. BPC-157 NO pathway modula…